Postmarketing Benefit-Risk Assessment for Erythropoiesis-Stimulating Agents Using a Health Care Database
Crossref DOI link: https://doi.org/10.1177/2168479016656029
Published Online: 2016-12-30
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugitani, Yasuo
Udagawa, Yukio
Matsuda, Shinichi
Yamada, Kana
Miyawaki, Natsuko
Konishi, Ichiro
Text and Data Mining valid from 2016-11-01
Article History
Received: 22 March 2016
Accepted: 24 May 2016
First Online: 30 December 2016